<?xml version="1.0" encoding="UTF-8"?>
<p>The Rubini strain was derived from a child of the same name presenting typical clinical signs and symptoms of mumps infection. A live attenuated mumps vaccine virus strain for human diploid cells was developed at the Swiss Serum and Vaccine Institute, Berne [
 <xref rid="B105-ijerph-17-01686" ref-type="bibr">105</xref>]. Attenuation of the wild virus was performed by isolation and serial passage in WI-38 human diploid cells, specific pathogen-free hen eggs and MRC-5 human diploid cells [
 <xref rid="B105-ijerph-17-01686" ref-type="bibr">105</xref>]. A mumps vaccine containing the Rubini strain was approved and commercialized in Switzerland in 1985, and over four million people worldwide had received this vaccine by 1990, [
 <xref rid="B74-ijerph-17-01686" ref-type="bibr">74</xref>].
</p>
